Johnson & Johnson: Urinary Incontinence trials

The registry lists 10 Urinary Incontinence studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 1Phase 3 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive BladderCompletedNCT01369485Not applicableResults posted
• Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive BladderCompletedNCT03109379Phase 1
• TVT-SECUR A Pilot Study for the Treatment of Stress Urinary IncontinenceCompletedNCT00463554
• TVT Worldwide RegistryCompletedNCT00453739
• Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary IncontinenceCompletedNCT00304499Phase 3
• Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive BladderCompletedNCT00293839Phase 3
• A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.CompletedNCT00269750Phase 3
• A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary IncontinenceCompletedNCT00269724Phase 3
• A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime BedwettingCompletedNCT00240812Phase 2
• A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence (Urinary Leakage)CompletedNCT00196521Not applicable